| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |